← 產業報告目錄
Tafenoquine Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 123報告編號 APO-f300f2ac21
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Tafenoquine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tafenoquine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Tafenoquine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tafenoquine include Pharmacodia (Beijing) Co.,Ltd, Merck, GlaxoSmithKline Pharmaceuticals (GSK), WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., J & K Scientific LTD, BOC Sciences and Amadis Chemical Company Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tafenoquine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tafenoquine Market by Company
Pharmacodia (Beijing) Co.,Ltd
Merck
GlaxoSmithKline Pharmaceuticals (GSK)
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
J & K Scientific LTD
BOC Sciences
Amadis Chemical Company Limited
Tafenoquine Segment by Type
Powder
Pills
Tafenoquine Segment by Application
P. falciparum Treatment
Radical Cure of P.vivax
Prevention of Malaria Relapse
Tafenoquine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafenoquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tafenoquine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafenoquine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tafenoquine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tafenoquine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Tafenoquine Market Size (2021-2032)
2.2.2 Global Tafenoquine Sales (2021-2032)
2.2.3 Global Tafenoquine Market Average Price (2021-2032)
2.3 Tafenoquine by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Powder
2.3.3 Pills
2.4 Tafenoquine by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 P. falciparum Treatment
2.4.3 Radical Cure of P.vivax
2.4.4 Prevention of Malaria Relapse
3 Market Competitive Landscape by Manufacturers
3.1 Global Tafenoquine Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Tafenoquine Sales (K Units) of Manufacturers (2021-2026)
3.3 Global Tafenoquine Revenue of Manufacturers (2021-2026)
3.4 Global Tafenoquine Average Price by Manufacturers (2021-2026)
3.5 Global Tafenoquine Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Tafenoquine, Product Type & Application
3.8 Global Manufacturers of Tafenoquine, Established Date
3.9 Global Tafenoquine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Pharmacodia (Beijing) Co.,Ltd
4.1.1 Pharmacodia (Beijing) Co.,Ltd Company Information
4.1.2 Pharmacodia (Beijing) Co.,Ltd Business Overview
4.1.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
4.1.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments
4.2 Merck
4.2.1 Merck Company Information
4.2.2 Merck Business Overview
4.2.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Merck Tafenoquine Product Portfolio
4.2.5 Merck Recent Developments
4.3 GlaxoSmithKline Pharmaceuticals (GSK)
4.3.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
4.3.2 GlaxoSmithKline Pharmaceuticals (GSK) Business Overview
4.3.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
4.3.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
4.3.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments
4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
4.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
4.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview
4.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
4.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
4.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments
4.5 J & K Scientific LTD
4.5.1 J & K Scientific LTD Company Information
4.5.2 J & K Scientific LTD Business Overview
4.5.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
4.5.4 J & K Scientific LTD Tafenoquine Product Portfolio
4.5.5 J & K Scientific LTD Recent Developments
4.6 BOC Sciences
4.6.1 BOC Sciences Company Information
4.6.2 BOC Sciences Business Overview
4.6.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
4.6.4 BOC Sciences Tafenoquine Product Portfolio
4.6.5 BOC Sciences Recent Developments
4.7 Amadis Chemical Company Limited
4.7.1 Amadis Chemical Company Limited Company Information
4.7.2 Amadis Chemical Company Limited Business Overview
4.7.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
4.7.5 Amadis Chemical Company Limited Recent Developments
5 Global Tafenoquine Market Scenario by Region
5.1 Global Tafenoquine Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Tafenoquine Sales by Region: 2021-2032
5.2.1 Global Tafenoquine Sales by Region: 2021-2026
5.2.2 Global Tafenoquine Sales by Region: 2027-2032
5.3 Global Tafenoquine Revenue by Region: 2021-2032
5.3.1 Global Tafenoquine Revenue by Region: 2021-2026
5.3.2 Global Tafenoquine Revenue by Region: 2027-2032
5.4 North America Tafenoquine Market Facts & Figures by Country
5.4.1 North America Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Tafenoquine Sales by Country (2021-2032)
5.4.3 North America Tafenoquine Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Tafenoquine Market Facts & Figures by Country
5.5.1 Europe Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Tafenoquine Sales by Country (2021-2032)
5.5.3 Europe Tafenoquine Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Tafenoquine Market Facts & Figures by Country
5.6.1 Asia Pacific Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Tafenoquine Sales by Country (2021-2032)
5.6.3 Asia Pacific Tafenoquine Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Tafenoquine Market Facts & Figures by Country
5.7.1 South America Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Tafenoquine Sales by Country (2021-2032)
5.7.3 South America Tafenoquine Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Tafenoquine Market Facts & Figures by Country
5.8.1 Middle East and Africa Tafenoquine Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Tafenoquine Sales by Country (2021-2032)
5.8.3 Middle East and Africa Tafenoquine Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Tafenoquine Sales by Type (2021-2032)
6.1.1 Global Tafenoquine Sales by Type (2021-2032) & (K Units)
6.1.2 Global Tafenoquine Sales Market Share by Type (2021-2032)
6.2 Global Tafenoquine Revenue by Type (2021-2032)
6.2.1 Global Tafenoquine Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Tafenoquine Revenue Market Share by Type (2021-2032)
6.3 Global Tafenoquine Price by Type (2021-2032)
7 Segment by Application
7.1 Global Tafenoquine Sales by Application (2021-2032)
7.1.1 Global Tafenoquine Sales by Application (2021-2032) & (K Units)
7.1.2 Global Tafenoquine Sales Market Share by Application (2021-2032)
7.2 Global Tafenoquine Revenue by Application (2021-2032)
7.2.1 Global Tafenoquine Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Tafenoquine Revenue Market Share by Application (2021-2032)
7.3 Global Tafenoquine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Tafenoquine Value Chain Analysis
8.1.1 Tafenoquine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Tafenoquine Production Mode & Process
8.2 Tafenoquine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Tafenoquine Distributors
8.2.3 Tafenoquine Customers
9 Global Tafenoquine Analyzing Market Dynamics
9.1 Tafenoquine Industry Trends
9.2 Tafenoquine Industry Drivers
9.3 Tafenoquine Industry Opportunities and Challenges
9.4 Tafenoquine Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Tafenoquine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Tafenoquine Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Tafenoquine Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Tafenoquine Revenue of Manufacturers (2021-2026)
Table 9. Global Tafenoquine Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Tafenoquine Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Tafenoquine Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Tafenoquine, Product Type & Application
Table 14. Global Tafenoquine Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Tafenoquine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Pharmacodia (Beijing) Co.,Ltd Company Information
Table 19. Pharmacodia (Beijing) Co.,Ltd Business Overview
Table 20. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
Table 22. Pharmacodia (Beijing) Co.,Ltd Recent Developments
Table 23. Merck Company Information
Table 24. Merck Business Overview
Table 25. Merck Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Merck Tafenoquine Product Portfolio
Table 27. Merck Recent Developments
Table 28. GlaxoSmithKline Pharmaceuticals (GSK) Company Information
Table 29. GlaxoSmithKline Pharmaceuticals (GSK) Business Overview
Table 30. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
Table 32. GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments
Table 33. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
Table 34. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview
Table 35. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
Table 37. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments
Table 38. J & K Scientific LTD Company Information
Table 39. J & K Scientific LTD Business Overview
Table 40. J & K Scientific LTD Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. J & K Scientific LTD Tafenoquine Product Portfolio
Table 42. J & K Scientific LTD Recent Developments
Table 43. BOC Sciences Company Information
Table 44. BOC Sciences Business Overview
Table 45. BOC Sciences Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. BOC Sciences Tafenoquine Product Portfolio
Table 47. BOC Sciences Recent Developments
Table 48. Amadis Chemical Company Limited Company Information
Table 49. Amadis Chemical Company Limited Business Overview
Table 50. Amadis Chemical Company Limited Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Amadis Chemical Company Limited Tafenoquine Product Portfolio
Table 52. Amadis Chemical Company Limited Recent Developments
Table 53. Global Tafenoquine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 54. Global Tafenoquine Sales by Region (2021-2026) & (K Units)
Table 55. Global Tafenoquine Sales Market Share by Region (2021-2026)
Table 56. Global Tafenoquine Sales by Region (2027-2032) & (K Units)
Table 57. Global Tafenoquine Sales Market Share by Region (2027-2032)
Table 58. Global Tafenoquine Revenue by Region (2021-2026) & (US$ Million)
Table 59. Global Tafenoquine Revenue Market Share by Region (2021-2026)
Table 60. Global Tafenoquine Revenue by Region (2027-2032) & (US$ Million)
Table 61. Global Tafenoquine Revenue Market Share by Region (2027-2032)
Table 62. North America Tafenoquine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 63. North America Tafenoquine Sales by Country (2021-2026) & (K Units)
Table 64. North America Tafenoquine Sales by Country (2027-2032) & (K Units)
Table 65. North America Tafenoquine Revenue by Country (2021-2026) & (US$ Million)
Table 66. North America Tafenoquine Revenue by Country (2027-2032) & (US$ Million)
Table 67. Europe Tafenoquine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 68. Europe Tafenoquine Sales by Country (2021-2026) & (K Units)
Table 69. Europe Tafenoquine Sales by Country (2027-2032) & (K Units)
Table 70. Europe Tafenoquine Revenue by Country (2021-2026) & (US$ Million)
Table 71. Europe Tafenoquine Revenue by Country (2027-2032) & (US$ Million)
Table 72. Asia Pacific Tafenoquine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 73. Asia Pacific Tafenoquine Sales by Country (2021-2026) & (K Units)
Table 74. Asia Pacific Tafenoquine Sales by Country (2027-2032) & (K Units)
Table 75. Asia Pacific Tafenoquine Revenue by Country (2021-2026) & (US$ Million)
Table 76. Asia Pacific Tafenoquine Revenue by Country (2027-2032) & (US$ Million)
Table 77. South America Tafenoquine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 78. South America Tafenoquine Sales by Country (2021-2026) & (K Units)
Table 79. South America Tafenoquine Sales by Country (2027-2032) & (K Units)
Table 80. South America Tafenoquine Revenue by Country (2021-2026) & (US$ Million)
Table 81. South America Tafenoquine Revenue by Country (2027-2032) & (US$ Million)
Table 82. Middle East and Africa Tafenoquine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. Middle East and Africa Tafenoquine Sales by Country (2021-2026) & (K Units)
Table 84. Middle East and Africa Tafenoquine Sales by Country (2027-2032) & (K Units)
Table 85. Middle East and Africa Tafenoquine Revenue by Country (2021-2026) & (US$ Million)
Table 86. Middle East and Africa Tafenoquine Revenue by Country (2027-2032) & (US$ Million)
Table 87. Global Tafenoquine Sales by Type (2021-2026) & (K Units)
Table 88. Global Tafenoquine Sales by Type (2027-2032) & (K Units)
Table 89. Global Tafenoquine Sales Market Share by Type (2021-2026)
Table 90. Global Tafenoquine Sales Market Share by Type (2027-2032)
Table 91. Global Tafenoquine Revenue by Type (2021-2026) & (US$ Million)
Table 92. Global Tafenoquine Revenue by Type (2027-2032) & (US$ Million)
Table 93. Global Tafenoquine Revenue Market Share by Type (2021-2026)
Table 94. Global Tafenoquine Revenue Market Share by Type (2027-2032)
Table 95. Global Tafenoquine Price by Type (2021-2026) & (US$/Unit)
Table 96. Global Tafenoquine Price by Type (2027-2032) & (US$/Unit)
Table 97. Global Tafenoquine Sales by Application (2021-2026) & (K Units)
Table 98. Global Tafenoquine Sales by Application (2027-2032) & (K Units)
Table 99. Global Tafenoquine Sales Market Share by Application (2021-2026)
Table 100. Global Tafenoquine Sales Market Share by Application (2027-2032)
Table 101. Global Tafenoquine Revenue by Application (2021-2026) & (US$ Million)
Table 102. Global Tafenoquine Revenue by Application (2027-2032) & (US$ Million)
Table 103. Global Tafenoquine Revenue Market Share by Application (2021-2026)
Table 104. Global Tafenoquine Revenue Market Share by Application (2027-2032)
Table 105. Global Tafenoquine Price by Application (2021-2026) & (US$/Unit)
Table 106. Global Tafenoquine Price by Application (2027-2032) & (US$/Unit)
Table 107. Key Raw Materials
Table 108. Raw Materials Key Suppliers
Table 109. Tafenoquine Distributors List
Table 110. Tafenoquine Customers List
Table 111. Tafenoquine Industry Trends
Table 112. Tafenoquine Industry Drivers
Table 113. Tafenoquine Industry Restraints
Table 114. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Tafenoquine Product Image
Figure 5. Global Tafenoquine Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Tafenoquine Market Size (2021-2032) & (US$ Million)
Figure 7. Global Tafenoquine Sales (2021-2032) & (K Units)
Figure 8. Global Tafenoquine Average Price (US$/Unit) & (2021-2032)
Figure 9. Powder Product Image
Figure 10. Pills Product Image
Figure 11. P. falciparum Treatment Product Image
Figure 12. Radical Cure of P.vivax Product Image
Figure 13. Prevention of Malaria Relapse Product Image
Figure 14. Global Tafenoquine Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Tafenoquine Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Tafenoquine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Tafenoquine Sales by Region in 2025
Figure 20. Global Tafenoquine Revenue by Region in 2025
Figure 21. North America Tafenoquine Market Size by Country in 2025
Figure 22. North America Tafenoquine Sales Market Share by Country (2021-2032)
Figure 23. North America Tafenoquine Revenue Market Share by Country (2021-2032)
Figure 24. United States Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Europe Tafenoquine Market Size by Country in 2025
Figure 27. Europe Tafenoquine Sales Market Share by Country (2021-2032)
Figure 28. Europe Tafenoquine Revenue Market Share by Country (2021-2032)
Figure 29. Germany Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. France Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. U.K. Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Italy Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Netherlands Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Asia Pacific Tafenoquine Market Size by Country in 2025
Figure 35. Asia Pacific Tafenoquine Sales Market Share by Country (2021-2032)
Figure 36. Asia Pacific Tafenoquine Revenue Market Share by Country (2021-2032)
Figure 37. China Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Japan Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. South Korea Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. India Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Australia Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. China Taiwan Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Southeast Asia Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South America Tafenoquine Market Size by Country in 2025
Figure 46. South America Tafenoquine Sales Market Share by Country (2021-2032)
Figure 47. South America Tafenoquine Revenue Market Share by Country (2021-2032)
Figure 48. Mexico Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Brazil Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Argentina Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Middle East and Africa Tafenoquine Market Size by Country in 2025
Figure 52. Middle East and Africa Tafenoquine Sales Market Share by Country (2021-2032)
Figure 53. Middle East and Africa Tafenoquine Revenue Market Share by Country (2021-2032)
Figure 54. Turkey Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Saudi Arabia Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. UAE Tafenoquine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Global Tafenoquine Sales Market Share by Type (2021-2032)
Figure 58. Global Tafenoquine Revenue Market Share by Type (2021-2032)
Figure 59. Global Tafenoquine Price (US$/Unit) by Type (2021-2032)
Figure 60. Global Tafenoquine Sales Market Share by Application (2021-2032)
Figure 61. Global Tafenoquine Revenue Market Share by Application (2021-2032)
Figure 62. Global Tafenoquine Price (US$/Unit) by Application (2021-2032)
Figure 63. Tafenoquine Value Chain
Figure 64. Tafenoquine Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Tafenoquine Industry Opportunities and Challenges
提及公司
Pharmacodia (Beijing) Co.,LtdMerckGlaxoSmithKline Pharmaceuticals (GSK)WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.J & K Scientific LTDBOC SciencesAmadis Chemical Company Limited
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們